During the past decade, Instituto Ribeiraopretano de Combate Ao Cancer conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Ribeiraopretano de Combate Ao Cancer" #1 sponsor was "Celgene" with 1 trials, followed by "Eisai Inc." with 1 trials sponsored, "Helsinn Healthcare SA" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Morphotek" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Ribeiraopretano de Combate Ao Cancer" #1 collaborator was "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Ribeiraopretano de Combate Ao Cancer" are "Metastatic Breast Cancer" (2 trials), "Breast Cancer" (1 trials), "Breast Tumor" (1 trials), "Cancer of the Breast" (1 trials) and "Chemotherapy-Induced Nausea and Vomiting" (1 trials). Many other conditions were trialed in "Instituto Ribeiraopretano de Combate Ao Cancer" in a lesser frequency.

Most popular intervention types in "Instituto Ribeiraopretano de Combate Ao Cancer" are "Drug" (5 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Archival Tumor Tissue Sample" (1 trials), "Capecitabine" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Ribeiraopretano de Combate Ao Cancer" are 3 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Instituto Ribeiraopretano de Combate Ao Cancer". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Instituto Ribeiraopretano de Combate Ao Cancer, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Ribeiraopretano de Combate Ao Cancer, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".